Cosmo Bio CompanyLimited Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Cosmo Bio CompanyLimited heeft een totaal eigen vermogen van ¥9.5B en een totale schuld van ¥20.0M, wat de schuld-eigenvermogensverhouding op 0.2% brengt. De totale activa en totale passiva bedragen respectievelijk ¥11.3B en ¥1.9B. De EBIT Cosmo Bio CompanyLimited is ¥442.0M waardoor de rentedekking -7 is. Het heeft contanten en kortetermijnbeleggingen van ¥3.0B.

Belangrijke informatie

0.2%

Verhouding schuld/eigen vermogen

JP¥20.00m

Schuld

Rente dekkingsratio	-7x
Contant	JP¥3.04b
Aandelen	JP¥9.48b
Totaal verplichtingen	JP¥1.85b
Totaal activa	JP¥11.33b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Cosmo Bio CompanyLimited's (TSE:3386) Shareholders Have More To Worry About Than Only Soft Earnings

Aug 12

Cosmo Bio CompanyLimited (TYO:3386) Is Experiencing Growth In Returns On Capital

May 09

Cosmo Bio Company,Limited (TYO:3386) Vies For A Place In Your Dividend Portfolio: Here's Why

Mar 23

Cosmo Bio Company,Limited's (TYO:3386) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 02

Will The ROCE Trend At Cosmo Bio CompanyLimited (TYO:3386) Continue?

Feb 07

Does Cosmo Bio CompanyLimited's (TYO:3386) Share Price Gain of 30% Match Its Business Performance?

Jan 17

Should Cosmo Bio Company,Limited (TYO:3386) Be Part Of Your Dividend Portfolio?

Dec 23

Do Fundamentals Have Any Role To Play In Driving Cosmo Bio Company,Limited's (TYO:3386) Stock Up Recently?

Dec 02

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ¥7.1B ) 3386 } overtreffen de korte termijn passiva ( ¥908.0M ).

Langlopende schulden: De kortetermijnactiva 3386 ( ¥7.1B ) overtreffen de langetermijnschulden ( ¥946.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 3386 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 3386 is de afgelopen 5 jaar gedaald van 0.3% naar 0.2%.

Schuldendekking: De schuld van 3386 wordt goed gedekt door de operationele kasstroom ( 990% ).

Rentedekking: 3386 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Cosmo Bio CompanyLimited Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Third quarter 2024 earnings released: EPS: JP¥5.66 (vs JP¥0.86 in 3Q 2023)

Cosmo Bio Company,Limited to Report Q3, 2024 Results on Nov 07, 2024

Cosmo Bio CompanyLimited's (TSE:3386) Shareholders Have More To Worry About Than Only Soft Earnings

Second quarter 2024 earnings released: EPS: JP¥4.79 (vs JP¥16.64 in 2Q 2023)

Cosmo Bio Company,Limited (TSE:3386) announces an Equity Buyback for 400,000 shares, representing 6.83% for ¥300 million.

Upcoming dividend of JP¥14.00 per share

Cosmo Bio Company,Limited to Report Q2, 2024 Results on Aug 05, 2024

First quarter 2024 earnings released: EPS: JP¥39.42 (vs JP¥45.41 in 1Q 2023)

Cosmo Bio Company,Limited to Report Q1, 2024 Results on May 09, 2024

Full year 2023 earnings released: EPS: JP¥75.83 (vs JP¥89.06 in FY 2022)

Cosmo Bio Company,Limited, Annual General Meeting, Mar 26, 2024

Upcoming dividend of JP¥16.00 per share at 3.1% yield

Cosmo Bio Company,Limited to Report Fiscal Year 2023 Results on Feb 14, 2024

Third quarter 2023 earnings released: EPS: JP¥0.86 (vs JP¥8.08 in 3Q 2022)

Cosmo Bio Company,Limited to Report Q3, 2023 Results on Nov 07, 2023

Second quarter 2023 earnings released: EPS: JP¥16.64 (vs JP¥7.06 in 2Q 2022)

Upcoming dividend of JP¥14.00 per share at 3.2% yield

Cosmo Bio Company,Limited to Report Q2, 2023 Results on Aug 04, 2023

First quarter 2023 earnings released: EPS: JP¥45.58 (vs JP¥63.19 in 1Q 2022)

Full year 2022 earnings released: EPS: JP¥89.06 (vs JP¥127 in FY 2021)

Full year 2022 earnings released: EPS: JP¥89.06 (vs JP¥127 in FY 2021)

Upcoming dividend of JP¥20.00 per share

Cosmo Bio Company,Limited to Report Fiscal Year 2022 Results on Feb 14, 2023

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: JP¥8.08 (vs JP¥21.58 in 3Q 2021)

Cosmo Bio Company,Limited to Report Q3, 2022 Results on Nov 07, 2022

Second quarter 2022 earnings released: EPS: JP¥7.06 (vs JP¥27.13 in 2Q 2021)

Upcoming dividend of JP¥16.00 per share

Cosmo Bio Company,Limited to Report Q2, 2022 Results on Aug 04, 2022

First quarter 2022 earnings released: EPS: JP¥63.19 (vs JP¥56.78 in 1Q 2021)

Less than half of directors are independent

Cosmo Bio Company,Limited to Report Q1, 2022 Results on May 10, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Cosmo Bio Company,Limited, Annual General Meeting, Mar 23, 2022

Upcoming dividend of JP¥24.00 per share

Third quarter 2021 earnings released: EPS JP¥21.58 (vs JP¥21.09 in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥27.13 (vs JP¥36.78 in 2Q 2020)

Upcoming dividend of JP¥12.00 per share

First quarter 2021 earnings released: EPS JP¥56.78 (vs JP¥39.14 in 1Q 2020)

Cosmo Bio CompanyLimited (TYO:3386) Is Experiencing Growth In Returns On Capital

Full year 2020 earnings released: EPS JP¥114 (vs JP¥39.98 in FY 2019)

Cosmo Bio Company,Limited (TYO:3386) Vies For A Place In Your Dividend Portfolio: Here's Why

Cosmo Bio Company,Limited's (TYO:3386) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Full year 2020 earnings released: EPS JP¥114 (vs JP¥39.98 in FY 2019)

New 90-day high: JP¥1,330

Will The ROCE Trend At Cosmo Bio CompanyLimited (TYO:3386) Continue?

New 90-day high: JP¥1,314

Does Cosmo Bio CompanyLimited's (TYO:3386) Share Price Gain of 30% Match Its Business Performance?

Should Cosmo Bio Company,Limited (TYO:3386) Be Part Of Your Dividend Portfolio?

Upcoming Dividend of JP¥26.00 Per Share

New 90-day low: JP¥1,135

Cosmo Bio Company,Limited to Report Fiscal Year 2020 Final Results on Feb 12, 2021

Do Fundamentals Have Any Role To Play In Driving Cosmo Bio Company,Limited's (TYO:3386) Stock Up Recently?

Third quarter 2020 earnings released: EPS JP¥21.09

Third quarter 2020 earnings released: EPS JP¥21.09

New 90-day low: JP¥1,140

Cosmo Bio Company,Limited to Report Q3, 2020 Results on Nov 06, 2020

First half earnings released

Earnings released

New 90-day high - JP¥1,328

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven